AUSTIN DUPREY: Open Payments
NPI 1427691757 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 41 payments from 16 companies in 2025. Trend: 2023 $1,289 · 2024 $1,033 · 2025 $1,423
Food & beverage: $1,423
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 14 | $497 |
| BLUEWIND MEDICAL | 1 | $165 |
| PFIZER INC. | 3 | $165 |
| Janssen Biotech, Inc. | 2 | $128 |
| Antares Pharma, Inc. | 4 | $85 |
| Boston Scientific Corporation | 1 | $71 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $48 |
| Azurity Pharmaceuticals, Inc. | 2 | $42 |
| UROGEN PHARMA, INC. | 2 | $41 |
| Endo USA, Inc. | 2 | $39 |
Products named: GEMTESA, REVI, XTANDI, ERLEADA, XYOSTED, General - Kidney Stone Disease, JOURNAVX, AZMIRO.
Industry payments across OH — which companies pay providers there.
